Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Jan 22 2021 | JCF Call for Papers: Focus Issue on “Challenges at the Intersection of Pharmacotherapy and HF” HFSA News Journal of Cardiac Failure Read More Jan 21 2021 | Dr. Barry Massie, Past President of the Heart Failure Society of America, Passes HFSA News In The News Read More Jan 18 2021 | Heart Failure Awareness 365: Research, Clinical Trials, and Patient Advocacy Patient News Heart Failure Awareness 365 Patient Resource Read More Jan 13 2021 | US FDA accepts supplemental New Drug Application for Jardiance® (empagliflozin) for adults with heart failure with reduced ejection fraction Industry News In The News Industry Read More Jan 10 2021 | HFSA President's Update: January 2021 HFSA News President's Updates Read More Pagination First page « First Previous page ‹ Previous … Page 85 Page 86 Page 87 Page 88 Current page 89 Page 90 Page 91 Page 92 Page 93 … Next page Next › Last page Last »
Jan 22 2021 | JCF Call for Papers: Focus Issue on “Challenges at the Intersection of Pharmacotherapy and HF” HFSA News Journal of Cardiac Failure Read More
Jan 21 2021 | Dr. Barry Massie, Past President of the Heart Failure Society of America, Passes HFSA News In The News Read More
Jan 18 2021 | Heart Failure Awareness 365: Research, Clinical Trials, and Patient Advocacy Patient News Heart Failure Awareness 365 Patient Resource Read More
Jan 13 2021 | US FDA accepts supplemental New Drug Application for Jardiance® (empagliflozin) for adults with heart failure with reduced ejection fraction Industry News In The News Industry Read More
